Company: MIRA
Filing Date: 2025-03-24
Form Type: 8-K
Source: 0001641172-25-000199
Chunk: 1

Company: MIRA PHARMACEUTICALS, INC.
Filing Date: 2025-03-24
Form: 8-K
Item: Item 9.01
Chunk 1
---
Item
9.01 Financial Statements and Exhibits.

  (d)      Exhibits.  

  Exhibit      Description                                                                                                               
      No.                                                                                                                                
     10.1      Binding Letter of Intent by and between MIRA Pharmaceuticals, Inc., and SKNY Pharmaceuticals, Inc. dated March 19, 2025.  
 ─────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────
      104      Cover                                                                                                                     

SIGNATURES

Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.

                      MIRA                                          
  Dated:              By:                        /s/                
                      Name:                      Erez               
                      Title:                     Chief